Neurology

TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy AgingTVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy Aging

TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy Aging

HLI is one of the most established, global longevity science companies and committed to accelerating living to 100+ years of…

8 months ago
TeleSpecialists Earns ISO 9001:2015 Recertification from Bureau Veritas, Reinforcing Commitment to Quality ExcellenceTeleSpecialists Earns ISO 9001:2015 Recertification from Bureau Veritas, Reinforcing Commitment to Quality Excellence

TeleSpecialists Earns ISO 9001:2015 Recertification from Bureau Veritas, Reinforcing Commitment to Quality Excellence

Telemedicine pioneer's quality resources and services are recognized by recent recertification FORT MYERS, Fla., Sept. 17, 2024 /PRNewswire/ -- TeleSpecialists,…

8 months ago
CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 CongressCureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress

CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress

Preliminary immunogenicity results demonstrate induction of cancer antigen-specific T-cell responses in 77% of evaluable patients following CVGBM monotherapy84% of immune…

8 months ago
Johnson & Johnson seeks first EU approval of nipocalimab to treat a broad population of patients living with antibody-positive generalised myasthenia gravisJohnson & Johnson seeks first EU approval of nipocalimab to treat a broad population of patients living with antibody-positive generalised myasthenia gravis

Johnson & Johnson seeks first EU approval of nipocalimab to treat a broad population of patients living with antibody-positive generalised myasthenia gravis

Marks first EMA submission for nipocalimab, an investigational treatment that binds with high affinity and specificity to block FcRn and…

8 months ago
Biogen Board Appoints Two New Independent DirectorsBiogen Board Appoints Two New Independent Directors

Biogen Board Appoints Two New Independent Directors

Dr. Lloyd Minor and Prof Sir Menelas Pangalos bring significant scientific expertise and considerable experience in medicine research and developmentCAMBRIDGE,…

8 months ago
FDA Grants Rare Pediatric Disease Designation to NS-050/NCNP-03 for the Treatment of Duchenne Muscular DystrophyFDA Grants Rare Pediatric Disease Designation to NS-050/NCNP-03 for the Treatment of Duchenne Muscular Dystrophy

FDA Grants Rare Pediatric Disease Designation to NS-050/NCNP-03 for the Treatment of Duchenne Muscular Dystrophy

PARAMUS, N.J., Sept. 10, 2024 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon…

8 months ago
Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical ResearchLifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and…

8 months ago
JuneBrain Receives MDIC Advanced Manufacturing Clearing House Award; Selects Compliance Group to Implement Siemens Polarion Design Quality SystemJuneBrain Receives MDIC Advanced Manufacturing Clearing House Award; Selects Compliance Group to Implement Siemens Polarion Design Quality System

JuneBrain Receives MDIC Advanced Manufacturing Clearing House Award; Selects Compliance Group to Implement Siemens Polarion Design Quality System

LIBERTYVILLE, Ill.--(BUSINESS WIRE)--#SaMD--JuneBrain is excited to announce our selection to receive a grant award from the Medical Device Innovation Consortium’s…

8 months ago